{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:42:36Z","timestamp":1790289756966,"version":"4.1.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"Supplement_I","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Current evidence supports device-based transcatheter interventions for the management of patients with structural heart disease, proving well their safety and efficacy; transcatheter aortic valve implantation (TAVI), transcatheter edge-to-edge repair (TEER) of mitral or tricuspid valves, and left atrial appendage occlusion (LAAO) are expanding their role in contemporary practice. Currently, guidelines recommend performing TAVI in \u2018Heart Valve Center\u2019 with interventional cardiology and institutional on-site cardiac surgery (iOSCS), while no site limitation has been defined for TEER and LAAO. The growing number of candidates for transcatheter interventions generates long waiting times with negative consequences on mortality, morbidity, hospitalization, and functional deterioration. Therefore, a debate on the feasibility of TAVI in centres without iOSCS has been set up. Data from randomized controlled trials and registries failed to document any difference in outcomes and in conversion rate to emergent surgical bailout in centres with or without iOSCS; on the other hand, a direct relationship with TAVI complications has been clearly documented for learning curve and centre volume. Therefore, the role of iOSCS for TAVI, as well as for other transcatheter interventions, should be carefully explored.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suac108","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T15:20:08Z","timestamp":1668266408000},"page":"I201-I205","source":"Crossref","is-referenced-by-count":5,"title":["On site cardiac surgery for structural heart interventions: a fence to mend?"],"prefix":"10.1093","volume":"24","author":[{"given":"Melissa","family":"Foglietta","sequence":"first","affiliation":[{"name":"Department of Cardiology , ASL 2 Abruzzo, Chieti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Radico","sequence":"additional","affiliation":[{"name":"Department of Cardiology , ASL 2 Abruzzo, Chieti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Appignani","sequence":"additional","affiliation":[{"name":"Department of Cardiology , ASL 2 Abruzzo, Chieti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Aquilani","sequence":"additional","affiliation":[{"name":"Cath Lab at SS. Annunziata Hospital , ASL 2 Abruzzo, Chieti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Di Fulvio","sequence":"additional","affiliation":[{"name":"Department of Cardiology , ASL 2 Abruzzo, Chieti"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-6010","authenticated-orcid":false,"given":"Marco","family":"Zimarino","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Intensive Care Unit , ASL 2 Abruzzo, Chieti"},{"name":"Department of Neuroscience, Imaging and Clinical Sciences, \u2018G. D\u2019Annunzio\u2019 University of Chieti-Pescara"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"2022111417524149700_suac108-B1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2022111417524149700_suac108-B2","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2022111417524149700_suac108-B3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJMoa1300610","article-title":"Nonemergency PCI at hospitals with or without on-site cardiac surgery","volume":"368","author":"Jacobs","year":"2013","journal-title":"N Engl J Med"},{"key":"2022111417524149700_suac108-B4","article-title":"Can transcatheter aortic valve implantation [TAVI] be performed at institutions without on-site cardiac surgery department?","volume":"41","author":"Kobo","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"2022111417524149700_suac108-B5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jcin.2019.04.026","article-title":"Incidence and outcomes of surgical bailout during TAVR: insights from the STS\/ACC TVT registry","volume":"12","author":"Pineda","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jcin.2018.06.044","article-title":"The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry","volume":"11","author":"Wassef","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B7","doi-asserted-by":"crossref","first-page":"e009026","DOI":"10.1161\/CIRCINTERVENTIONS.120.009026","article-title":"Early adverse impact of transfusion after transcatheter aortic valve replacement: a propensity-matched comparison from the TRITAVI registry","volume":"13","author":"Zimarino","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/eurheartj\/ehw190","article-title":"Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients","volume":"37","author":"Eggebrecht","year":"2016","journal-title":"Eur Heart J"},{"key":"2022111417524149700_suac108-B9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcin.2019.02.006","article-title":"Transfemoral TAVR at hospitals without on-site cardiac surgery department in Spain: a multicenter registry","volume":"12","author":"Roa Garrido","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jcin.2018.07.015","article-title":"Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement","volume":"11","author":"Egger","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13019-019-0891-1","article-title":"Failed MitraClip therapy: surgical revision in high-risk patients","volume":"14","author":"Mkalaluh","year":"2019","journal-title":"J Cardiothorac Surg"},{"key":"2022111417524149700_suac108-B12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11886-021-01553-9","article-title":"Complications following MitraClip implantation","volume":"23","author":"Schnitzler","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"2022111417524149700_suac108-B13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ccd.29153","article-title":"Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system","volume":"97","author":"Isogai","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022111417524149700_suac108-B14","first-page":"243","article-title":"Incidence, prevention, and management of periprocedural complications of left atrial appendage occlusion","volume":"7","author":"Thakkar","year":"2018","journal-title":"Interv Cardiol Clin"},{"key":"2022111417524149700_suac108-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I201\/47030495\/suac108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I201\/47030495\/suac108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:56:40Z","timestamp":1668448600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/24\/Supplement_I\/I201\/6823853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":15,"journal-issue":{"issue":"Supplement_I","published-online":{"date-parts":[[2022,11,12]]},"published-print":{"date-parts":[[2022,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac108","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,12]]},"published":{"date-parts":[[2022,11,12]]}}}